{"id":"W1117787078","doi":"10.1016/j.clml.2015.07.650","title":"Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Centre Hospitalier de l’Université de Montréal; University of Alberta; McGill University; Princess Margaret Cancer Centre; Thunder Bay Regional Health Sciences Centre; McMaster University; Hôpital Maisonneuve-Rosemont; St. Paul's Hospital; Memorial University of Newfoundland; University of British Columbia; Lakehead University; University of Toronto; Western University; University of Windsor; Jewish General Hospital","funders":"World Health Organization","keywords":"Medicine; Polycythemia vera; Phlebotomy; Ruxolitinib; Internal medicine; Oncology; Myelofibrosis; Thrombosis; Disease; Pegylated interferon; Intensive care medicine; Immunology; Bone marrow; Ribavirin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004785669,0.0006252087,0.0007306113,0.002161742,0.003288309,0.003836806,0.002074784,0.003715842,0.00689569],"category_scores_gemma":[0.005431918,0.0001896427,0.0007942765,0.002371803,0.003644368,0.001841037,0.00139434,0.005800783,0.0005600642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02937408,"about_ca_system_score_gemma":0.07698399,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5896841,"about_ca_topic_score_gemma":0.8304804,"domain_scores_codex":[0.9980614,0.0002956698,0.0001216194,0.0001208171,0.0008519859,0.0005484925],"domain_scores_gemma":[0.9926108,0.0009722849,0.0003790075,0.00007044357,0.003803683,0.0021639],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004550955,0.0003005911,0.01175958,0.001040129,0.0001176115,0.001807281,0.0007808572,0.001632536,0.001177557,0.03339168,0.3441427,0.6033943],"study_design_scores_gemma":[0.0002852923,0.0002262509,0.01650009,0.003261557,0.0002036471,0.00226981,0.002253731,0.0007212374,0.0003029663,0.008414195,0.9654488,0.0001124587],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.006361863,0.4199605,0.0005439774,0.5302413,0.004881595,0.0000441127,0.00018966,0.00003080427,0.03774622],"genre_scores_gemma":[0.09553595,0.7575749,0.005356547,0.1098257,0.02095979,0.00008561104,0.0005793775,0.00004517029,0.0100371],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.4103159,"threshold_uncertainty_score":0.8254647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06055785830586164,"score_gpt":0.3405440413676777,"score_spread":0.2799861830618161,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}